Charles Schwab’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-20,023
| Closed | -$26K | – | 3642 |
|
|
2021
Q4 | $26K | Hold |
20,023
| – | – | ﹤0.01% | 3568 |
|
|
2021
Q3 | $44K | Hold |
20,023
| – | – | ﹤0.01% | 3466 |
|
|
2021
Q2 | $55K | Buy |
+20,023
| New | +$55K | ﹤0.01% | 3356 |
|
|
2018
Q2 | – | Sell |
-7,263
| Closed | -$78K | – | 3163 |
|
|
2018
Q1 | $78K | Hold |
7,263
| – | – | ﹤0.01% | 3054 |
|
|
2017
Q4 | $307K | Hold |
7,263
| – | – | ﹤0.01% | 2869 |
|
|
2017
Q3 | $400K | Buy |
7,263
+1,038
| +17% | +$57.2K | ﹤0.01% | 2779 |
|
|
2017
Q2 | $1.16M | Buy |
6,225
+1,525
| +32% | +$283K | ﹤0.01% | 2406 |
|
|
2017
Q1 | $562K | Hold |
4,700
| – | – | ﹤0.01% | 2604 |
|
|
2016
Q4 | $467K | Hold |
4,700
| – | – | ﹤0.01% | 2677 |
|
|
2016
Q3 | $527K | Hold |
4,700
| – | – | ﹤0.01% | 2598 |
|
|
2016
Q2 | $483K | Buy |
4,700
+2,250
| +92% | +$231K | ﹤0.01% | 2599 |
|
|
2016
Q1 | $226K | Hold |
2,450
| – | – | ﹤0.01% | 2860 |
|
|
2015
Q4 | $354K | Buy |
+2,450
| New | +$354K | ﹤0.01% | 2797 |
|